Seer, Inc. (California) (SEER)
2.18
-0.15
(-6.44%)
USD |
NASDAQ |
Oct 06, 16:00
2.18
0.00 (0.00%)
After-Hours: 20:00
Seer Cash from Operations (Quarterly) : -9.571M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.571M |
| March 31, 2026 | -15.44M |
| December 31, 2025 | -10.81M |
| September 30, 2025 | -7.566M |
| June 30, 2025 | -14.66M |
| March 31, 2025 | -11.42M |
| December 31, 2024 | -11.46M |
| September 30, 2024 | -14.13M |
| June 30, 2024 | -10.07M |
| March 31, 2024 | -10.46M |
| December 31, 2023 | -10.19M |
| September 30, 2023 | -14.41M |
| June 30, 2023 | -15.13M |
| Date | Value |
|---|---|
| March 31, 2023 | -19.33M |
| December 31, 2022 | -14.26M |
| September 30, 2022 | -13.37M |
| June 30, 2022 | -14.00M |
| March 31, 2022 | -19.15M |
| December 31, 2021 | -12.37M |
| September 30, 2021 | -8.756M |
| June 30, 2021 | -10.35M |
| March 31, 2021 | -14.87M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -4.779M |
| March 31, 2020 | -5.074M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Champions Oncology, Inc. | -0.492M |
| Medpace Holdings, Inc. | 162.01M |
| Avantor, Inc. | 178.20M |
| Personalis, Inc. | -25.77M |
| Adaptive Biotechnologies Corp. | -6.40M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -11.47M |
| Cash from Financing (Quarterly) | -0.205M |
| Free Cash Flow | -44.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1737 |
| Free Cash Flow to Equity (Quarterly) | -8.942M |
| Free Cash Flow to Firm (Quarterly) | -9.58M |
| Free Cash Flow Yield | -36.32% |